Showing results (1-10 of 104) with videos related to
Sort By:
Pageof 11
Annals of Surgical Oncology|March 1, 1996
Vaccine therapy for cancerD C Linehan, P S Goedegebuure, T J EberleinSurgery|April 1, 1995
Immunoregulatory effects of CD4+ T helper subsets in human melanomaK Y Lee, P S Goedegebuure, D C Linehan, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1995
Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancerD C Linehan, P S Goedegebuure, G E Peoples, et al.Proceedings of the National Academy of Sciences of the United States of America|January 17, 1995
Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptideG E Peoples, P S Goedegebuure, R Smith, et al.European Journal of Immunology|May 1, 1997
The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytesM Peiper, P S Goedegebuure, D C Linehan, et al.Cellular Immunology|September 1, 1995
Shared T cell epitopes in epithelial tumorsG E Peoples, R C Smith, D C Linehan, et al.Immunologic Research|January 1, 1995
The role of CD4+ tumor-infiltrating lymphocytes in human solid tumorsP S Goedegebuure, T J EberleinSurgery|August 1, 1997
Generation of peptide-specific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cellsM Peiper, P S Goedegebuure, T J EberleinCellular Immunology|February 1, 1997
Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancerP S Goedegebuure, C C Douville, J M Doherty, et al.Surgical Oncology|February 1, 1995
In vitro stimulation of ovarian tumour-associated lymphocytes with a peptide derived from HER2/neu induces cytotoxicity against autologous tumourD C Linehan, G E Peoples, D T Hess, et al.Pageof 11